ARKG Investment Tracker
Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.
0Follow
732Followers
0Topic
0Badge
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 680,732 shares, the number of shares held decreased 5.75% compared to the previous period and now represents 7.01% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 570,233 shares, the number of shares held decreased 4.65% compared to the previous period and now represents 2.19% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 121,248 shares, the number of shares held increased 1.04% compared to the previous period and now represents 2.28% of the total position.
ARKG Investment Tracker position change: Increased position in Recursion Pharmaceuticals, Inc. by 115,614 shares, the number of shares held increased 1.04% compared to the previous period and now represents 6.85% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 72,215 shares, the number of shares held decreased 0.58% compared to the previous period and now represents 2.13% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 1,064 shares, the number of shares held increased 4.25% compared to the previous period and now represents 1.05% of the total position.
ARKG Investment Tracker position change: Decreased position in Veeva by 1,245 shares, the number of shares held decreased 1.61% compared to the previous period and now represents 1.51% of the total position.
ARKG Investment Tracker position change: Decreased position in Pacific Biosciences of California by 38,355 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 1.96% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 192,675 shares, the number of shares held decreased 1.6% compared to the previous period and now represents 7.41% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 420 shares, the number of shares held decreased 1.61% compared to the previous period and now represents 1.06% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 101,513 shares, the number of shares held increased 0.83% compared to the previous period and now represents 2.15% of the total position.
ARKG Investment Tracker position change: Decreased position in Recursion Pharmaceuticals, Inc. by 38,235 shares, the number of shares held decreased 0.31% compared to the previous period and now represents 6.34% of the total position.
ARKG Investment Tracker position change: Increased position in Veeva by 836 shares, the number of shares held increased 1.09% compared to the previous period and now represents 1.53% of the total position.
ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 124,463 shares, the number of shares held decreased 10.83% compared to the previous period and now represents 3.75% of the total position.
ARKG Investment Tracker position change: Decreased position in Vertex Pharmaceuticals by 812 shares, the number of shares held decreased 3.03% compared to the previous period and now represents 1.02% of the total position.
ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 49,997 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 3.5% of the total position.
ARKG Investment Tracker position change: Increased position in Vertex Pharmaceuticals by 168 shares, the number of shares held increased 0.62% compared to the previous period and now represents 1.03% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 496,698 shares, the number of shares held increased 4.23% compared to the previous period and now represents 2.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 41,361 shares, the number of shares held decreased 1.86% compared to the previous period and now represents 4.08% of the total position.
ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 31,213 shares, the number of shares held decreased 1.4% compared to the previous period and now represents 9.61% of the total position.
Go to Tiger App to see more news